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Background: Major depressive disorder (MDD) is a chronic mental illness which affects an estimated 3% of the
Japanese population. Many patients with MDD report painful physical symptoms, and research outside of Japan
suggests such patients may represent a subtype of depression which is more severe and difficult to treat. There
is no evidence available about the characteristics or incremental burden of these patients in Japan. The objective
of this study was to quantify the incremental burden of physical pain among individuals in Japan diagnosed
with depression.
Methods: Data for individuals age 18 and older who reported a physician diagnosis of depression were obtained
from the Japan National Health and Wellness Survey (NHWS). Respondents who also reported physical pain were
matched to respondents who did not report pain using propensity scores and compared using bivariate statistics.
Measures included Patient Health Questionnaire (PHQ-9) for depression severity, Medical Outcomes Study 12-Item
Short Form Survey Instrument (SF-12v2) for health-related quality of life, the Work Productivity and Activity
Impairment (WPAI) for work and activity impairment, and 6-month report of health care use.
Results: Individuals with depression who reported physical pain had higher PHQ-9 depression scores (14.3 vs.
11.1, p<0.001), lower health-related quality of life (Mental Component Summary score [MCS] 29.1 vs. 32.0, p<0.01;
Physical Component Summary score [PCS] 43.0 vs. 47.2, p<0.001; health utility [SF-6D] 0.567 vs. 0.613, p<0.001),
more presenteeism (46.3% vs. 36.8%, p<0.01), more overall work impairment (51.4% vs. 42.3%, p<0.01), more activity
impairment (55.4% vs. 43.9%, p<0.001), and reported using more health care provider visits in the prior 6 months
(17.7 vs. 12.8, p<0.01) as well as hospitalizations (1.7 vs. 0.8, p<0.05) relative to propensity-score matched controls
without pain. Absenteeism (13.1% vs. 11.4%, p=0.51) and emergency room visits (0.31 vs. 0.35, p=0.76) were not
significantly different between the two matched groups.
Conclusions: Individuals whose depression is accompanied by physical pain have a higher burden of illness than
those whose depression does not include physical pain. Clinicians should take the presence of pain into account
and consider treating both the physical and emotional symptoms of these patients.
Keywords: Depression, Pain, Painful physical symptoms, Quality of life, Work productivity, Health care useBackground
Major Depressive Disorder (MDD) is a severe recurring
illness associated with depressed mood, loss of interest
or pleasure, feelings of guilt or low self-worth, disturbed
sleep or appetite, psychomotor agitation or slowing, low
energy, poor concentration, and risk of suicide. Depres-
sion has a considerable impact on both patients with the
condition as well as on broader society [1-3]. MDD is one* Correspondence: Jeffrey.vietri@kantarhealth.com
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prevalence of approximately 3% in Japan according to the
World Health Organization Composite International
Diagnostic Interview [4]. While the prevalence of mood
disorders such as MDD is considerably lower in Japan
than in many Western countries, there are significant
cohort differences in susceptibility to mood disorders,
with higher prevalence in younger generations [5]. The
higher lifetime prevalence expected for these younger
people suggests an increase in the societal burden of de-
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toms as well [6], which many exacerbate this burden.
As is the case with depression, chronic pain conditions
have been found to lead to substantial disability [7-10].
Furthermore, previous research has shown that a high
proportion of patients with depression experience a range
of painful physical symptoms [11,12]. The subset of de-
pressed patients who experience such pain symptoms ap-
pears to have a particularly high level of disability. Relative
to depressed patients without comorbid pain, individuals
with depression and pain have greater limitations in daily
activities [11,12], have worse health related quality of
life (HRQoL) [11-15], and are more likely to be un-
employed due to disability [11,16]. Patients with both
depression and pain also use more inpatient and out-
patient health care resources and are more expensive to
treat [11,14,17-20]. In fact, it has been suggested that
patients with depression and painful physical symptoms
may constitute a distinct subpopulation of patients
which is more difficult to treat [21].
The connection between painful physical symptoms
and greater depression severity, lower quality of life, and
greater health care use was recently demonstrated in a
multi-country prospective study of individuals present-
ing with an acute depressive episode in East Asia [22].
In that study, painful physical symptoms were reported
by approximately half of the patients enrolled, and such
symptoms were associated with clinically important dec-
rements in quality of life at 3 months post-baseline [22].
This decrement was maintained after adjusting for co-
variates including baseline level of depression [23]. Simi-
larly, worse pain symptoms were associated with lower
remission rates of depression [24]. However, Japan was
not included in the aforementioned prospective study, and
little real-world data from Japan has been reported regard-
ing either the incremental burden of physical pain on
patients with depression or the burden on the Japanese
health care system. Research describing patient-reported
health outcomes such as HRQoL and impairment to
work and daily activities among these individuals is par-
ticularly scarce.
Therefore the objective of this study was to assess the
incremental burden of physical pain in real-world pa-
tients with depression in Japan, including the association




Data were provided by the Japan National Health and
Wellness Survey (NHWS; Kantar Health, NY, USA), an
annual internet-based survey of the general population
aged 18 and older. Potential respondents for the NHWS
were selected from an opt-in survey panel throughrandom sampling stratified by age and gender to match
the Japanese population aged 18 years and older. This
project included two years of Japan NHWS data, with
25,000 respondents collected in 2010 and 30,000 in 2011.
These two years of data were collected independently of
one another but combined to provide a more robust sam-
ple size for the current analysis. Respondents who partici-
pated in both years of the survey were identified and only
the more recent response was included in the analyses.
In addition to membership in the survey panel, respon-
dents were required to read and write Japanese, be at
least 18 years old, and provide informed consent. All in-
formation was collected through self-report. The proto-
col and questionnaire for the NHWS were reviewed and
approved by Essex Institutional Review Board (Lebanon,
New Jersey, USA).Measures
Depression
The NHWS includes questions on experience, diagnosis,
and treatment of a broad variety of medical conditions,
one of which is depression. Those who indicated they had
experienced depression in the prior 12 months were then
asked if their depression had been diagnosed by a doctor.
Respondents who indicated a diagnosis by a doctor were
considered to have depression and were asked additional
details regarding the year of diagnosis, the type of phys-
ician, and whether they were currently using a prescrip-
tion medication for their depression. The diagnostic
criteria used and setting of the diagnosis were not
assessed in the survey.Depression symptoms
Depression symptoms were assessed using the PHQ-9
[25], a validated scale used to screen for depression and
to assess its severity, translated into Japanese. This scale
measures depression through the frequency of anhedo-
nia, depressed mood, sleep disturbance, lack of energy,
appetite disturbance, negative self-feelings, difficulty
concentrating, psychomotor retardation or agitation,
and thoughts of self-harm in the prior two weeks. The
severity of depression was assigned according to the
standard cutoff scores: 5, 10, 15, and 20 points for mild,
moderate, moderately severe, and severe depression, re-
spectively. The total score can also be considered as a
continuous variable. A single-item measure of the inter-
ference of these symptoms is also included in the instru-
ment. The PHQ-9 was not included in the 2011 Japan
NHWS, and comparisons of depression severity therefore
included fewer respondents than other measures which
were common across both 2010 and 2011. In addition to
the PHQ-9, respondents also rated the severity of their de-
pression as mild, moderate, or severe.
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The NHWS asks respondents to indicate whether they
have experienced pain in the 12 months preceding the
survey (yes or no); those who indicated experiencing
pain were considered to have painful physical symptoms.
In order to avoid attributing pain from obvious physical
causes to painful symptoms associated with depression,
respondents who reported pain caused by broken bones,
cancer, dental problems, menstrual cycle, post herpetic
neuralgia, surgery or a medical procedure, or phantom
limb pain (neuropathic pain following amputation) were
excluded from the analyses.
Health-related quality of life (HRQoL)
The Japanese language version of the revised Medical
Outcomes Study 12-Item Short Form Survey Instrument
(SF-12v2) was used to measure HRQoL. This is a multi-
purpose, generic HRQoL instrument comprising of 12
questions [26] developed from the widely used SF-36v2
[27]. Two summary scores calculated from this measure
were used: the physical component summary (PCS)
score, an index of overall physical functioning, and the
mental component summary (MCS) score, which is an
index of mental and emotional health. Scores can be
interpreted relative to the US population average of 50
with a standard deviation of 10, with higher scores indi-
cating better HRQoL.
Responses to the SF-12v2 were also used to generate
health state utilities according to the SF-6D algorithm, a
preference-based, single index measure for health using
general population values [28]. The SF-6D index has
interval scoring properties and yields summary scores
on a theoretical 0–1 scale (with an empirical floor of
0.3). Higher scores indicate better (more preferred)
health status, with 1 being equivalent to perfect health.
Work productivity and activity impairment
Work productivity was assessed using the Japanese
language version of the Work Productivity and Activity
Impairment (WPAI) questionnaire, which assesses absen-
teeism (work time missed), presenteeism (impairment
while at work), overall work productivity impairment (a
combination of absenteeism and presenteeism), and activ-
ity impairment (impairment in daily activities) due to
health problems over the prior seven days [29]. All are re-
ported as percentages, with higher numbers indicating
greater impairment. Only respondents who reported being
full-time or part-time employed provided data for absen-
teeism, presenteeism, and overall work impairment. All re-
spondents provided data for activity impairment.
Health care resource use
Health care resource use is assessed in the NHWS as
all-cause health care provider (HCP) visits, emergencyroom (ER) visits, and hospitalizations in the 6 months
prior to the survey. HCP visits were calculated by sum-
ming the self-reported number of visits to specific types
of health care providers (e.g., general internist, psych-
iatrist, allergist, dentist, nurse, etc.).
Analysis
The analysis was conducted in three phases. First, pa-
tients with depression were compared according to the
presence of physical pain using t-tests for continuous
variables and chi-square tests for categorical variables.
This analysis served to identify patient characteristics
that were associated with physical pain and describe the
differences in outcomes, irrespective of the presence of
potentially confounding patient characteristics across the
two groups.
The second step of the analysis was the assignment of
propensity scores. Propensity scores were calculated using
a binary logistic regression predicting the presence of pain
within the sample reporting a diagnosis of depression. The
regression incorporated age, sex, completion of university
education, household income category, body mass index
(BMI) category, cigarette smoking, alcohol use, exercise,
length of depression diagnosis, type of diagnosing phys-
ician, and Charlson comorbidity index (CCI) as predictors.
These variables were selected for inclusion either because
of their potential relationships with outcomes, observed
differences in unmatched comparisons, or both. Variables
that differed according to the presence of pain that could
be considered outcomes, including employment status,
depression severity, HRQoL, work and activity impair-
ment, and health care resource use were not used as
predictors in the regression. The predicted values from
this regression were used as propensity scores to match
each respondent with depression and pain to a single re-
spondent whose depression did not include pain using a
greedy matching algorithm.
The third and final step in the analysis was compari-
son of the two matched samples (depression with and
without pain) using independent-samples t-tests and chi-
square tests. These comparisons provide an incremental




The disposition of Japan NHWS respondents is presented
in Figure 1. A total of 54,977 individuals completed the
Japan NHWS across 2010 and 2011, and 2,147 of those re-
spondents indicated experiencing depression in the prior
12 months. Of these, 1,964 indicated a doctor diagnosis
of depression. Eighty-nine (89) were excluded due to the
source or type of pain experienced, resulting in 1,875
respondents with a physician diagnosis of depression
Figure 1 Disposition of NHWS respondents in matched comparisons.
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pain, physical pain was reported by 18.8% (n=352) of the
sample. The average respondent was 40.6 years old and
had been diagnosed with depression 6.2 years prior to the
survey. A total of 80% reported current treatment for de-
pression with a prescription medication. The sample was
52.6% males, 63.2% were employed, 50.6% had completed
a 4-year college degree or greater, and 44.3% reported be-
ing married or living with a partner.
Unmatched comparisons
Demographic and health characteristics are presented in
Table 1. Pain was associated with different demographic
characteristics among those reporting a diagnosis of de-
pression. Those reporting pain were more likely to be
women, less likely to have a 4-year university degree, less
likely to be employed, and tended to fall into the lower
income categories than those without pain. The propor-
tion of respondents using alcohol, smoking cigarettes,
and exercising in the prior month were similar across
the two groups, though respondents who reported pain
differed in the distribution of BMI categories and had
higher CCI scores.
Depression characteristics are presented in Table 2.
Regardless of whether pain was present or not, approxi-
mately four out of every five respondents in the sample
had been diagnosed by a psychiatrist, and a similarproportion was currently using a prescription for depres-
sion. Those with pain had been diagnosed with depres-
sion an average of one year longer, and their depression
was more severe. This finding of greater depression se-
verity among those with pain was consistent whether
assessed through self-rated severity, PHQ-9 score, or the
distribution of PHQ-9 severity categories. Patients with
pain also rated their depression as making it harder to
work or function than those without pain.
Patients with depression and pain also had worse out-
comes in terms of quality of life and functioning as mea-
sured by the SF-12v2 and WPAI, and reported more
frequent use of health care resources (Table 3). Those
with pain had decrements of 2.8 points on the MCS
score and 4.5 points on the PCS score relative to those
who did not report pain, and SF-6D health utility scores
were .05 points lower than those who had depression
without pain. Impairment to work and daily activities
were significantly greater among those with pain relative
to those without pain, and HCP visits were also more
frequent, though ER visits and hospitalizations were not
significantly different.
Matching procedure
A total of 56 respondents (14 with pain and 42 without)
were excluded from the logistic regression because of
missing data for length of diagnosis. Higher odds of
Table 1 Sociodemographic and health characteristics by the presence of physical pain
Depressed without pain (N=1523) Depressed with pain (N=352)
n % n % p-value
Female 687 45.1% 202 57.4% <0.001
Marital status 0.039
Married or living with partner 671 44.1% 160 45.5%
Single, never married 702 46.1% 143 40.6%
Divorced 150 9.8% 49 13.9%
Annual household income 0.070
Less than ¥ 3,000,000 382 25.1 114 32.4
¥ 3,000,000 to ¥ 4,999,999 371 24.4 71 20.2
¥ 5,000,000 to ¥ 7,999,999 342 22.5 71 20.2
¥ 8,000,000 or more 295 19.4 67 19.0
Decline to answer 133 8.7 29 8.2
University degree or greater 799 52.5% 150 42.6% 0.001
Employed 981 64.4% 204 58.0% 0.024
BMI categories 0.010
Underweight 176 11.6% 56 15.9%
Normal 870 57.1% 190 54.0%
Overweight 286 18.8% 78 22.2%
Obese 123 8.1% 14 4.0%
Decline to answer 68 4.5% 14 4.0%
Drinks alcohol 1065 69.9% 255 72.4% 0.351
Smokes cigarettes 475 31.2% 117 33.2% 0.456
Vigorous exercise in past month 624 41.0% 153 43.5% 0.392
Mean SD Mean SD p-value
Age 40.3 12.2 41.5 12.1 0.118
BMI (n=1460, 339) 23.32 5.07 22.73 4.86 0.052
CCI 0.22 0.69 0.53 2.12 0.006*
Note: p-values for comparison of frequencies are from omnibus Pearson chi-square test; p-values for comparison of means are from t-test; asterisk indicates
p-value adjusted for violation of homogeneity of variance assumption; BMI: Body mass index; CCI: Charlson comorbidity index.
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score, longer duration of depression, and lack of a uni-
versity degree (Table 4). The presence of pain also varied
with BMI category. Five respondents with pain were not
able to be matched to a control without pain, resulting
in a total of 333 respondents with both depression and
pain and 333 matched controls.
Matched comparisons
There were no significant differences between the two
matched groups in sociodemographics and health char-
acteristics (all p > 0.40; Table 5) or in the depression-
specific variables included in the regression (i.e., type of
diagnosing doctor and length of diagnosis, both p>0.74;
Table 6). Though not included in the matching equa-
tion, current use of a prescription medication for de-
pression was similar across those with and without pain
(Table 6).However, differences in severity of depression between
those with and without pain remained significant in the
matched comparisons when measured by the PHQ-9 total
score or PHQ-9 severity categories. In contrast, self-
ratings of severity did not differ (Table 6). The ratings of
how much the depression made it hard to work or func-
tion (which is not asked of respondents without depres-
sion symptoms on the PHQ-9) showed a non-significant
trend for more interference among those with pain
(p=.09; Table 6).
The pattern of poorer HRQoL, more work and activity
impairment, and greater health care use among those
with painful physical symptoms noted in the unmatched
comparison was confirmed in the matched comparisons
(Table 7). HRQoL was worse in those with depression
and pain compared to those with depression alone, with
the mean MCS score 2.9 points lower, mean PCS score
4.2 points lower, and mean health utility score .046 points
Table 2 Depression characteristics by the presence of physical pain
Depressed without pain (N=1523) Depressed with pain (N=352)
n % n % p-value
Diagnosing physician (n=1,481; 338) 0.027
General internist 156 10.5% 53 15.7%
Psychiatrist 1250 84.4% 268 79.3%
Other 75 5.1% 17 5.0%
Currently use prescription 1229 80.7% 274 77.8% 0.226
Depression severity (self-rated) 0.005
Mild 614 40.3% 117 33.2%
Moderate 697 45.8% 165 46.9%
Severe 212 13.9% 70 19.9%
Depression severity categories (PHQ-9; n=824; 185) <0.001
None 162 19.7% 13 7.0%
Mild 239 29.0% 47 25.4%
Moderate 149 18.1% 40 21.6%
Moderately severe 140 17.0% 41 22.2%
Severe 134 16.3% 44 23.8%
Problems made it hard to work/function (PHQ-9; n=769; 182) 0.012
Not difficult at all 126 16.4% 16 8.8%
Somewhat difficult 426 55.4% 101 55.5%
Very difficult 139 18.1% 35 19.2%
Extremely difficult 78 10.1% 30 16.5%
Mean SD Mean SD p-value
Length of depression diagnosis (years) (n=1481; 338) 6.0 5.7 7.1 7.1 0.010*
PHQ-9 total score (n=824; 185) 11.3 7.4 14.1 7.1 <0.001
Note: p-values for comparison of frequencies are from omnibus Pearson chi-square test; p-values for comparison of means are from t-test; asterisk indicates
p-value adjusted for violation of homogeneity of variance assumption.
Table 3 General patient-reported outcomes by the presence of physical pain
Depressed without pain (N=1523) Depressed with pain (N=352)
Mean SD Mean SD p-value
HRQoL
Mental Component Summary 31.9 11.9 29.1 11.2 <0.001
Physical Component Summary 47.5 8.2 43.0 8.8 <0.001
Health utility score (SF-6D) 0.615 0.099 0.567 0.093 <0.001
Work impairment
Absenteeism (%) (n=914; 191) 14.8 29.1 13.7 26.4 0.649
Presenteeism (%) (n=895; 191) 38.0 26.7 46.4 25.7 <0.001
Overall work impairment (%) (n=914; 191) 45.5 31.6 51.7 29.2 0.009*
Activity impairment (%) 45.1 27.7 55.3 25.8 <0.001*
Health care use (past 6 months)
HCP visits 12.7 12.2 17.6 17.2 <0.001*
ER visits 0.29 1.63 0.32 1.42 0.745
Hospitalizations 1.16 6.95 1.74 7.37 0.178*
Note: HRQoL: Health-related quality of life; ER: Emergency room; HCP: Health care provider; p-values for comparison of frequencies are from omnibus Pearson
chi-square test; p-values for comparison of means are from t-test; asterisk indicates p-value adjusted for violation of homogeneity of variance assumption.
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Table 4 Odds ratios of reported pain among individuals
with depression in Japan
95% confidence
limits
Odds ratio Lower Upper p-value
Age (1 year) 0.999 0.987 1.011 0.856
Female 1.601 1.219 2.104 <0.001
Marital status (overall) 0.326
Married/living with partner Reference
Single, never married 0.830 0.607 1.134 0.134
Divorced 1.122 0.748 1.682 0.295
Household income (overall) 0.157
Less than ¥ 3,000,000 Reference
¥ 3,000,000 to ¥ 4,999,999 0.673 0.471 0.963 0.333
¥ 5,000,000 to ¥ 7,999,999 0.679 0.466 0.988 0.384
¥ 8,000,000 or more 0.677 0.457 1.001 0.395
Decline to answer 0.821 0.511 1.319 0.670
University degree or greater 0.744 0.572 0.967 0.027
BMI category (overall) 0.010
Underweight Reference
Normal 0.772 0.533 1.119 0.520
Overweight 1.048 0.672 1.634 0.011
Obese 0.372 0.191 0.724 0.008
Decline to answer 0.624 0.313 1.246 0.604
Drinks 1.200 0.908 1.587 0.200
Smokes 1.095 0.836 1.435 0.509
Exercises 1.141 0.889 1.466 0.300
CCI 1.398 1.197 1.634 <0.001
Diagnosing doctor (overall) 0.241
General internist Reference
Psychiatrist 0.735 0.514 1.052 0.288
Other 0.784 0.417 1.474 0.757
Length of diagnosis (1 year) 1.024 1.004 1.045 0.018
Note: p-value is from Wald chi-square test in binary logistic regression; BMI:
Body mass index; CCI: Charlson comorbidity index.
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among those with pain, and impairment in non-work ac-
tivities was 12% greater in absolute terms. As in the un-
matched comparisons, those with pain visited HCPs more
frequently, with 4.9 more visits on average in a 6-month
period, and 0.9 more hospitalizations during the same
time, though rates of ER use were similar in those with
and without physical pain.
Discussion
The current study demonstrates that individuals in Japan
with depression and painful physical symptoms have both
more-severe depression and impaired health outcomes
relative to those whose depression does not includepainful symptoms. A broad variety of health outcomes are
impacted, including HRQoL, work productivity impair-
ment, and health care resource use. The impact of phys-
ical pain among these patients remained significant after
propensity score matching equated the groups on a variety
of potential confounders, including age, sex, education,
level of income, length of diagnosis, type of diagnosing
physician, and comorbidity burden, among others.
Consistent with previous research [22,24], the current
study found an association between physical pain and
the severity of depression, which was reflected in both
the MCS score, which is a broad index of mental and
emotional health, and the PHQ-9 score, which is specific
to depression. These findings further support the idea that
depression which includes painful physical symptoms is a
more severe subtype of depression [21]. The difference in
MCS scores was just below the 3-point threshold often
considered the minimally important difference (MID) for
this measure [27]. Not surprisingly, physical pain showed
an impact outside of the measures designed to assess
mental and emotional well-being. The difference in PCS
scores observed was greater than the 3-point MID thresh-
old. The .046 difference observed in SF-6D utility scores is
also substantial, and greater than the .030 interval often
considered the MID for that measure [30]. The impact of
pain was not limited to HRQoL, as those with pain re-
ported 1.26 times the presenteeism according to the
WPAI, 1.22 times the overall work impairment, and
1.26 times the activity impairment reported by those
without pain. Health care use was likewise elevated,
with nearly 5 more HCP visits on average per patient
during the 6-month recall period and one additional
hospitalization among those with pain relative to those
without pain.
The prevalence of pain among those with depression
was considerably lower in the current study (18%) than
was reported among other East Asians (52%) [22,24]. It
is not clear to what extent the difference reflects differ-
ences in the populations studied versus differences in
measurements used in the studies. The aforementioned
prospective study found differences in the prevalence of
painful physical symptoms across the countries included
in the study using a common definition, which was a
threshold of greater than or equal to 2 points on the Som-
atic Symptoms Inventory pain scale [31]. However, that
scale is not used in the NHWS. Instead, the current study
required the patient to identify pain as condition they had
experienced in the prior 12 months, and this difference in
assessment may have been partially responsible for the
lower prevalence reported here. Differences in measures
used also prevent comparing the magnitude of the differ-
ences between those with and without pain between this
study and the previous one, as the measures used to assess
depression severity and HRQoL also differed.
Table 5 Sociodemographic and general health characteristics in the matched sample by the presence of physical pain
Depressed without pain Depressed with pain
(N=333) (N=333)
n % n % p-value
Female 184 55.3% 191 57.4% 0.584
Marital status 0.818
Married 159 47.7% 151 45.3%
Single, never married 129 38.7% 136 40.8%
Divorced 45 13.5% 46 13.8%
Annual household income 0.986
Less than ¥ 3,000,000 110 33.0% 109 32.7%
¥ 3,000,000 to ¥ 4,999,999 62 18.6% 67 20.1%
¥ 5,000,000 to ¥ 7,999,999 67 20.1% 66 19.8%
¥ 8,000,000 or more 66 19.8% 62 18.6%
Decline to answer 28 8.4% 29 8.7%
University degree or greater 150 45.0% 140 42.0% 0.434
Employed 198 59.5% 194 58.3% 0.753
BMI categories 0.808
Underweight 56 16.8% 51 15.3%
Normal 181 54.4% 181 54.4%
Overweight 76 22.8% 74 22.2%
Obese 12 3.6% 14 4.2%
Decline to answer 8 2.4% 13 3.9%
Drinks alcohol 250 75.1% 241 72.4% 0.428
Smokes cigarettes 117 35.1% 112 33.6% 0.683
Vigorous exercise in past month 144 43.2% 145 43.5% 0.938
Mean SD Mean SD p-value
Age 41.7 12.6 41.5 11.9 0.815
BMI (n=318; 320) 22.7 4.0 22.8 4.9 0.701
CCI 0.37 1.11 0.42 0.95 0.524
Note: p-values for comparison of frequencies are from omnibus Pearson chi-square test; p-values for comparison of means are from t-test; BMI: Body mass index;
CCI: Charlson comorbidity index.
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itations. Details regarding the diagnosis of depression
were not available in the survey data. Indeed, some indi-
viduals in the present study may not have met diagnostic
criteria for MDD at the time of the survey. Other
NHWS respondents may have been suffering from
depression but were not included here due to lack of
diagnosis being required for inclusion in this study.
While it was not possible to corroborate the diagnosis
self-reported in NHWS with medical records, the high
prevalence of self-reported prescription use for depres-
sion and the results of the PHQ-9 provide additional evi-
dence that the sample studied here is suffering from
depression. Approximately 80% of the sample was cur-
rently using a prescription medication for depression,
and the vast majority of patients in this study had symp-
toms of depression, with 82.7% of respondents rated ashaving at least mild depression symptoms on the PHQ-
9. Likewise, the definition of pain in the current study
differed from previous studies, and no specific pain
scale was administered to all respondents of the NHWS.
Incorporating a scale such as the Somatic Symptoms In-
ventory to screen individuals for pain may have identi-
fied additional respondents with depression who were
experiencing pain but who did not indicate pain as one
of their conditions in the survey. The cross-sectional
and correlational nature of the survey did not allow for
assessment of the time course of the physical symptoms,
and it was not clear whether individuals had painful
physical symptoms at the onset of the emotional com-
ponents of the depressive episode or whether the pain
developed at another time. The propensity scores were
generated by a regression analysis, the results of which
may have differed if different variables were included, or
Table 6 Depression characteristics by presence of physical pain (matched comparisons)
Depressed without pain Depressed with pain
(N=333) (N=333)
n % n % p-value
Diagnosing physician 0.921
General internist 52 15.6% 50 15.0%
Psychiatrist 266 79.9% 266 79.9%
Other 15 4.5% 17 5.1%
Currently use prescription 260 78.1% 265 79.6% 0.635
Depression severity (self-rated) 0.184
Mild 128 38.4% 110 33.0%
Moderate 156 46.8% 159 47.7%
Severe 49 14.7% 64 19.2%
Depression severity (PHQ-9; n=194; 177) <0.001
None 42 21.6% 11 6.2%
Mild 48 24.7% 45 25.4%
Moderate 44 22.7% 38 21.5%
Moderately severe 33 17.0% 41 23.2%
Severe 27 13.9% 42 23.7%
Problems made it hard to work/function (PHQ-9; n=180; 175) 0.088
Not difficult at all 28 15.6% 16 9.1%
Somewhat difficult 102 56.7% 96 54.9%
Very difficult 33 18.3% 34 19.4%
Extremely difficult 17 9.4% 29 16.6%
Mean SD Mean SD p-value
Length of depression diagnosis (years) 7.0 6.7 6.8 6.5 0.742
PHQ-9 total score (n=198; 175) 11.1 7.3 14.3 7.1 <0.001
Note: p-values for comparison of frequencies are from omnibus Pearson chi-square test; p-values for comparison of means are from t-test.
Table 7 General patient-reported outcomes by the presence of physical pain (matched comparisons)
Depressed without pain Depressed with pain
(N=333) (N=333)
HRQoL Mean SD Mean SD p-value
Mental Component Summary 32.0 11.9 29.1 11.3 0.001
Physical Component Summary 47.2 8.4 43.0 8.8 <0.001
Health utility score (SF-6D) 0.613 0.097 0.567 0.094 <0.001
Work impairment
Absenteeism (%) (n=188; 181) 11.4 24.9 13.1 25.7 0.510
Presenteeism (%) (n=181; 191) 36.8 26.6 46.3 25.5 <0.001
Overall work impairment (%) (n=191;182) 42.3 30.4 51.4 29.0 0.003
Activity impairment (%) 43.9 27.1 55.4 25.7 <0.001
Health care use (past 6 months)
HCP visits 12.8 12.7 17.7 17.2 <0.001
ER visits 0.35 1.87 0.31 1.36 0.758
Hospitalizations 0.78 4.11 1.72 7.27 0.041
Note: HRQoL: Health-related quality of life; ER: Emergency room; HCP: Health care provider; p-values are from t-test.
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different way. Finally, while the matching procedure
equalized the groups on a number of measured potential
confounders, it is possible that an unmeasured variable
differed across the matched groups and was responsible
for some portion of the differences observed.
Conclusion
In conclusion, the presence of physical pain among de-
pression patients in Japan appears to have an effect simi-
lar to that seen in other countries, where it is associated
with more-severe depression, treatment resistance, worse
health outcomes, greater use of health care resources, and
lower productivity. Clinicians caring for these patients
should take the presence of physical pain into account
and consider treating both the physical and emotional
symptoms of depression.
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